13F filing recap · Q3 2011

What did Abrams Capital Management buy in Q3 2011?

Reported stock-position changes between this filing and the previous one.

Stock value

$1.14B

Positions

Estimated turnover

42.2%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

TEVATeva Pharmaceutical Industries Limited$80.81Mreported value+2.17M shares CEPHCephalon Inc$75.05Mreported value+930.0K shares GOOGLAlphabet Inc.$51.50Mreported value+100.0K shares GNWGenworth Financial, Inc.$17.22Mreported value+3.00M shares SNYSanofi$14.16Mreported value+13.36M shares OHIOmega Healthcare Investors, Inc.$7.96Mreported value+500.0K shares SAFTSafety Insurance Group Inc$3.02Mreported value+79.8K shares RBSPRTRoyal Bank of Scotland Group Plc$500.0Kreported value+48.4K shares RYRoyal Bank of Scotland Group Plc$491.0Kreported value+46.8K shares

Increased positions

HRBH&R Block, Inc.$154.80Mreported value+1.45M shares+14.2%LAMRLamar Advertising Co/new$149.74Mreported value+6.01M shares+216.3%SLMSlm Corp$142.70Mreported value+1.57M shares+15.8%CFNCarefusion Corporation$45.15Mreported value+185.2K shares

Reduced positions

ARBArbitron Inc$97.37Mreported value-20.9K shares-0.7%

Exited positions

MHFIS&P Global Inc.$42.53Mprior reported value-1.01M shares-100.0%